The U.S. Food and Drug Administration (FDA) has granted Priority Review to Rituxan (rituximab) in combination with glucocorticoids for…
Articles by Patricia Inacio, PhD
ANCA-associated vasculitis patients in Korea have a high prevalence of thyroid dysfunction, with the condition affecting mainly those who…
InflaRx will soon launch a Phase 2 clinical trial in Europe to assess the safety and effectiveness of IFX-1 —…
Elevated levels of the CD64 protein on the surface of neutrophils – a type of immune cell – accurately distinguishes…
The occurrence of a severe infection during the first month of care is a strong predictor of one-year mortality among…
Standard therapies used to ANCA-associated vasculitis (AAV), like cyclophosphamide or Rituxan (rituximab), appear to be of benefit in patients who…
The frequency of ANCA-associated vasculitis (AAV) appears to increase with exposure to carbon monoxide and colder climates, with patients more often…
The presence of atypical ANCA antibodies in people with underlying eye inflammatory disease is not linked to severe vessel inflammation…
A case report of a patient with eosinophilic granulomatosis with polyangiitis (EGPA), with the disease affecting both the heart and…
Children with eosinophilic granulomatosis with polyangiitis (EGPA) have specific disease symptoms that differ from those seen in adults with the…